Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novartis ag save search
Europe Frontotemporal Dementia Market Research Report 2023: Growing Prevalence of Dementia & Increasing Number of Clinical Trials - Competition, Forecasts & Opportunities to 2028
Published: 2023-04-26 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -4.57%
H: 0.22%
C: -1.98%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.22%
H: 0.65%
C: -1.09%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: -2.04%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.66%
H: 0.18%
C: -0.9%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.3%
C: -2.63%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 1.23%
H: 27.27%
C: -15.76%
europe report dementia trials research growing market
Intellia Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Recent Company Progress
Published: 2021-08-05 (Crawled : 12:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: 0.24%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 1.32%
H: 2.47%
C: 2.35%
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: -2.46%
H: 24.2%
C: 15.24%
financial results results
Voyager Therapeutics Announces License Option Agreement with Novartis for Target-Specific Access to Next-Generation TRACER™ AAV Capsids for Gene Therapy Programs
Published: 2022-03-08 (Crawled : 07:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -4.98%
H: 0.0%
C: 0.0%
VYGR | $7.5 -0.66% -0.67% 520K
|
Health Technology
|
| O: 31.15%
H: 19.58%
C: 9.17%
trace novartis aav capsids gene therapy program license therapeutics therapy
Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
Published: 2022-03-08 (Crawled : 17:00) - voyagertherapeutics.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -4.98%
H: 0.0%
C: 0.0%
VYGR | $7.5 -0.66% -0.67% 520K
|
Health Technology
|
| O: 31.15%
H: 19.58%
C: 9.17%
therapeutics report results
2023 Inhalers Pipeline Research Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Published: 2024-01-17 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.78%
H: 0.59%
C: 0.57%
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 0.52%
H: 2.31%
C: -0.87%
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: -0.73%
H: 12.24%
C: 12.24%
companies report pipeline research key
REGENXBIO Reports Second Quarter 2021 Financial Results and Operational Highlights
Published: 2021-08-09 (Crawled : 20:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.35%
H: 0.33%
C: 0.15%
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
|
| O: 0.07%
H: 1.15%
C: -0.03%
RARE | News F | $42.37 -2.33% -2.38% 680K
|
Health Technology
|
| O: 1.14%
H: 1.44%
C: 0.89%
RGNX | $15.67 -2.73% -2.87% 570K
|
Health Technology
|
| O: -11.65%
H: 11.75%
C: 9.11%
financial results results
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.39%
H: 0.82%
C: -0.74%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.22%
H: 0.43%
C: -0.39%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -63.33%
H: 263.64%
C: 127.27%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.1%
H: 0.43%
C: -0.04%
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: -0.91%
H: 11.52%
C: 4.94%
drug report t-cell global therapy market
RNAi Drug Delivery Market worth $109.73 billion between 2022-2027- Exclusive report by Technavio
Published: 2023-07-27 (Crawled : 08:00) - prnewswire.com
RNAZ | $0.49 -2.39% -2.45% 110K
|
Professional, Scientific, and T...
|
| O: 2.57%
H: 3.43%
C: 0.47%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.17%
H: 0.35%
C: -2.67%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.7%
H: 0.12%
C: -0.76%
SLN | $22.75 3.32% 3.21% 310K
|
Health Technology
|
| O: 2.61%
H: 0.27%
C: -2.18%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
BNTC | $6.89 1.03% 1.02% 250K
|
Health Technology
|
| O: -8.92%
H: 9.49%
C: 0.59%
drug report market
REGENXBIO Reports Third Quarter 2021 Financial Results and Operational Highlights
Published: 2021-11-02 (Crawled : 20:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.7%
H: 0.82%
C: 0.82%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.59%
H: 0.67%
C: 0.4%
SLDB | $8.7 -6.05% -6.44% 110K
|
Health Technology
|
| O: 1.89%
H: 9.26%
C: 8.8%
RGNX | $15.67 -2.73% -2.87% 570K
|
Health Technology
|
| O: 4.62%
H: 1.4%
C: -1.41%
financial results results
Soft Contact Lens Market: 40% of Growth to Originate from APAC, Evolving Opportunities with BenQ Corp. & Cantor and Nissel Ltd. - Technavio
Published: 2022-09-07 (Crawled : 08:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 4.71%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.66%
H: 0.88%
C: 0.8%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.15%
H: 9.26%
C: 7.25%
growth
Insights on the Non-Melanoma Skin Cancer Treatment Global Market to 2026 - by Treatment Type, Indication, End-use and Region
Published: 2021-11-01 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.3%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.17%
H: 1.58%
C: 0.65%
ICAD | $1.54 -3.15% -3.25% 68K
|
Technology Services
|
| O: 0.0%
H: 0.85%
C: -0.57%
ARAY | $2.135 -3.39% -3.51% 630K
|
Health Technology
|
| O: 0.0%
H: 8.82%
C: 7.01%
treatment skin cancer cancer skin
Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
Published: 2021-08-05 (Crawled : 11:00) - biospace.com/
WPP | $48.18 0.15% 0.0% 440K
|
Commercial Services
|
| O: 3.0%
H: 1.2%
C: 0.85%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: 0.24%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: -0.09%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -2.23%
H: 8.36%
C: 1.6%
financial results results
Global Contact Lenses Market- Bausch Health Companies Inc., BenQ Materials Corp., Contamac Ltd., among others to contribute to the market growth |Industry Analysis, Market Trends, Opportunities and Forecast 2024
Published: 2021-03-11 (Crawled : 16:01) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.58%
H: 0.69%
C: 0.07%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.25%
H: 0.68%
C: -0.25%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -2.53%
H: 8.07%
C: 7.47%
growth
BeiGene Reports First Quarter 2022 Financial Results
Published: 2022-05-05 (Crawled : 12:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.39%
H: 0.15%
C: -1.07%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 0.98%
H: 7.7%
C: -2.09%
results
Uveitis Drugs Market, High Prevalence Of Eye Disorders And Associated Risk Factors Of Uveitis to Boost Market Growth - Technavio
Published: 2022-08-08 (Crawled : 22:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.28%
H: 0.8%
C: 0.13%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -7.02%
H: 7.55%
C: -4.6%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.24%
H: 1.11%
C: -0.31%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.56%
H: 1.04%
C: 0.58%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.03%
H: 1.02%
C: 0.47%
risk eye growth market
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.47%
H: 0.09%
C: -0.55%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 1.07%
H: 2.51%
C: -0.11%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 3.1%
H: 1.8%
C: -0.6%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 1.59%
H: 7.26%
C: 1.89%
financial results
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
IOVA | News M | $11.32 -3.41% -3.53% 5.3M
|
Health Technology
|
| O: 6.12%
H: 4.99%
C: 4.21%
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: 5.5%
H: 4.35%
C: 3.48%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 1.43%
H: 0.36%
C: -1.08%
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 2.58%
H: 23.12%
C: 20.85%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 5.71%
covid-19 research global immunotherapy report impact technology market
USD 8 Bn growth opportunity in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market | North America to emerge as key market | Technavio
Published: 2022-05-25 (Crawled : 04:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.42%
H: 2.73%
C: 2.73%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.26%
H: 3.13%
C: 2.96%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
PBYI | $5.01 0.4% 0.4% 290K
|
Health Technology
|
| O: -1.6%
H: 6.52%
C: 3.8%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.45%
H: 0.89%
C: 0.54%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 1.42%
H: 0.72%
C: 0.0%
america growth market her2- her2
Celcuity Announces Breast Cancer Clinical Trial Collaboration with MD Anderson, Novartis, and Puma Biotechnology to Study New Drug Regimen
Published: 2021-03-16 (Crawled : 01:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.14%
H: 0.82%
C: 0.7%
CELC | $17.22 5.06% 4.82% 230K
|
Commercial Services
|
| O: 1.19%
H: 6.37%
C: 0.66%
new drug collaboration cancer biotech drug iot breast cancer trial
Global Lupus Therapeutic Market to Surpass US$ 5,408.1 Million by 2030, Says Coherent Market Insights
Published: 2022-03-16 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.46%
H: 3.49%
C: 3.49%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
UCBJY | $63.676 -4.38% 7.2K
|
Manufacturing
|
| O: 1.41%
H: 2.33%
C: 0.04%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 2.07%
H: 1.62%
C: 1.56%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.26%
H: 0.31%
C: -0.39%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
AUPH | $5.01 4.16% 3.99% 1.6M
|
Health Technology
|
| O: 0.95%
H: 6.23%
C: 5.19%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -0.37%
lupus market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.